6,7-dimethoxy-1-(4'-fluorophenyl)-3,4-dihydroisoquinoline-2(1H)-sulfonamide | 1161432-38-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 四氢异喹啉
• 英文名称: 6,7-dimethoxy-1-(4'-fluorophenyl)-3,4-dihydroisoquinoline-2(1H)-sulfonamide
• 英文别名: 1-(4-fluorophenyl)-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-2-sulfonamide
• CAS: 1161432-38-7
• 化学式: C₁₇H₁₉FN₂O₄S
• 分子量: 366.413
• InChiKey: VGDQXHGPCZIYJG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  25
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  90.2
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  6,7-dimethoxy-1-(4'-fluorophenyl)-1,2,3,4-tetrahydrioisoquinoline 在 磺酰胺 作用下， 以 二甲氧基乙烷 为溶剂， 90.0 ℃ 、1.38 MPa 条件下， 反应 0.67h， 以70%的产率得到6,7-dimethoxy-1-(4'-fluorophenyl)-3,4-dihydroisoquinoline-2(1H)-sulfonamide
  参考文献：
  名称：

  Synthesis and evaluation of pharmacological profile of 1-aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamides

  摘要：

  In previous studies we identified several 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives displaying potent anticonvulsant effects in different animal models of epilepsy. With the aim to deepen the structure-activity relationships (SAR) for this class of compounds and identify novel anticonvulsant agents we synthesized a series of 1-aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamides. The new compounds incorporate the main features of the above-mentioned anticonvulsants and a sulfonamide function capable to inhibit the enzyme carbonic anhydrase (CA, EC 4.2.1.1), which represents an attractive target in epilepsy. Pharmacological effects were evaluated in vivo against audiogenic seizures in DBA/2 mice and in vitro against several CA isoforms. Some of the new molecules showed anticonvulsant properties better than topiramate, but weak inhibitory activity and low selectivity in enzymatic assay. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2009.03.066

文献信息

• Synthesis and evaluation of pharmacological profile of 1-aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamides
  作者：Rosaria Gitto、Stefania Ferro、Stefano Agnello、Laura De Luca、Giovanbattista De Sarro、Emilio Russo、Daniela Vullo、Claudiu T. Supuran、Alba Chimirri

  DOI：10.1016/j.bmc.2009.03.066

  日期：2009.5

  In previous studies we identified several 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives displaying potent anticonvulsant effects in different animal models of epilepsy. With the aim to deepen the structure-activity relationships (SAR) for this class of compounds and identify novel anticonvulsant agents we synthesized a series of 1-aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamides. The new compounds incorporate the main features of the above-mentioned anticonvulsants and a sulfonamide function capable to inhibit the enzyme carbonic anhydrase (CA, EC 4.2.1.1), which represents an attractive target in epilepsy. Pharmacological effects were evaluated in vivo against audiogenic seizures in DBA/2 mice and in vitro against several CA isoforms. Some of the new molecules showed anticonvulsant properties better than topiramate, but weak inhibitory activity and low selectivity in enzymatic assay. (C) 2009 Elsevier Ltd. All rights reserved.